Akari Therapeutics PLC
AKTX
$7.87+5.35%
End of day · as of Aug 25, 2026, 11:25 PM ET
Mkt cap
$17.25M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2024-06-30)
N/A
EPS (qtr ended 2024-06-30)
N/A
Gross Margin (qtr ended 2024-06-30)
N/A
Profit Margin (qtr ended 2024-06-30)
N/A
Beta
1.33
Div yield
N/A
Sector
Healthcare
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Latest reported AKTX revenue for 2024-06-30 was $0. Net income was -$7.6M. AKTX currently screens at market cap $17.2M.
Use this AKTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AKTX income, balance, and cash tables.
Akari Therapeutics PLC (AKTX) is a biotechnology company in the Healthcare sector.
Latest cached Akari Therapeutics PLC (AKTX) net income for Jun 30, 2024 was -$7.6M. Statements: https://lician.com/financials/aktx
Akari Therapeutics PLC (AKTX) market capitalization is $17.2M on the latest cached snapshot.
Akari Therapeutics PLC (AKTX) cached previous close $7.47; day range $7.69 – $8.10; volume 30,400. Session quote: https://lician.com/quote/aktx
Akari Therapeutics PLC (AKTX) latest cached earnings event is "AKTX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AKTX filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/aktx